Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

November 01, 2019; Volume 16,Issue 4

Editorial

  • You have access
    Capture a live-photo of tumor infiltrating T cell landscape at single cell resolution
    Xin Dong and Ruidong Xue
    Cancer Biology & Medicine November 2019, 16 (4) 619-622; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0146
  • You have access
    Clinical proteomics: a driving force for cancer therapeutic target discovery and precision medicine
    Hao Wang, Na Jiang, Yali Zhang and Ruibing Chen
    Cancer Biology & Medicine November 2019, 16 (4) 623-629; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0287

Review

  • You have access
    The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?
    Yulu Zhou, Yong Shen, Cong Chen, Xinbing Sui, Jingjing Yang, Linbo Wang and Jichun Zhou
    Cancer Biology & Medicine November 2019, 16 (4) 630-646; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0158
  • You have access
    Technical advances in NK cell-based cellular immunotherapy
    Fang Fang, Wei Wang, Minhua Chen, Zhigang Tian and Weihua Xiao
    Cancer Biology & Medicine November 2019, 16 (4) 647-654; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0187
  • You have access
    The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
    Wenxiao Jia, Qianqian Gao, Anqin Han, Hui Zhu and Jinming Yu
    Cancer Biology & Medicine November 2019, 16 (4) 655-670; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0144
  • You have access
    Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
    Tong Wang, Zhiyong Wang, Ruifang Niu and Liang Wang
    Cancer Biology & Medicine November 2019, 16 (4) 671-687; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0228
  • You have access
    The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
    Francisco Quiñonero, Cristina Mesas, Kevin Doello, Laura Cabeza, Gloria Perazzoli, Cristina Jimenez-Luna, Ana Rosa Rama, Consolación Melguizo and Jose Prados
    Cancer Biology & Medicine November 2019, 16 (4) 688-699; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0252
  • You have access
    Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer
    Guangbiao Zhou
    Cancer Biology & Medicine November 2019, 16 (4) 700-713; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0180
  • You have access
    Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
    Guilian Shi, Mingchuan Zhong, Fuli Ye and Xiaoming Zhang
    Cancer Biology & Medicine November 2019, 16 (4) 714-728; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0232

Original Article

  • You have access
    PADI3 induces cell cycle arrest via the Sirt2/AKT/p21 pathway and acts as a tumor suppressor gene in colon cancer
    Xiaotian Chang, Zhengbin Chai, Jiaorui Zou, Hongxing Wang, Yao Wang, Yabing Zheng, Hui Wu and Chunyan Liu
    Cancer Biology & Medicine November 2019, 16 (4) 729-742; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0065
  • You have access
    Inactivation of FOXO1 induces T follicular cell polarization and involves angioimmunoblastic T cell lymphoma
    Meifang Xu, Fei Wang, Hong Chen, Lin Liu, Wenwen Liu, Yinghong Yang, Qiaoling Zheng, Lihong Zhang, Xiaoxuan Li, Suxia Lin and Shengbing Zang
    Cancer Biology & Medicine November 2019, 16 (4) 743-755; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0115
  • You have access
    Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy
    Bin Liu, Wen Cao, Jin Cheng, Sisi Fan, Shaojun Pan, Lirui Wang, Jiaqi Niu, Yunxiang Pan, Yanlei Liu, Xiyang Sun, Lijun Ma, Jie Song, Jian Ni and Daxiang Cui
    Cancer Biology & Medicine November 2019, 16 (4) 756-770; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0112
  • You have access
    ILF2 cooperates with E2F1 to maintain mitochondrial homeostasis and promote small cell lung cancer progression
    Meng Zhao, Yahui Liu, Jiao Chang, Jin Qi, Ran Liu, Yongwang Hou, Yanhui Wang, Xinwei Zhang, Lu Qiao and Li Ren
    Cancer Biology & Medicine November 2019, 16 (4) 771-783; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0050
  • You have access
    Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis
    Yingbin Xie, Yanli Tan, Chao Yang, Xuehao Zhang, Can Xu, Xiaoxia Qiao, Jianglong Xu, Shaohui Tian, Chuan Fang and Chunsheng Kang
    Cancer Biology & Medicine November 2019, 16 (4) 784-796; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0143
  • You have access
    Nomogram based on albumin-bilirubin grade to predict outcome of the patients with hepatitis C virus-related hepatocellular carcinoma after microwave ablation
    Chao An, Xin Li, Xiaoling Yu, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Jie Yu and Ping Liang
    Cancer Biology & Medicine November 2019, 16 (4) 797-810; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0486
  • You have access
    The correlation and overlaps between PD-L1 expression and classical genomic aberrations in Chinese lung adenocarcinoma patients: a single center case series
    Jianghua Wu, Wei Sun, Haiyue Wang, Xiaozheng Huang, Xinyu Wang, Weiyang Jiang, Ling Jia, Ping Wang, Qin Feng and Dongmei Lin
    Cancer Biology & Medicine November 2019, 16 (4) 811-821; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0209

Guideline

  • You have access
    Breast cancer screening guideline for Chinese women
    Cancer Biology & Medicine November 2019, 16 (4) 822-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0321

Guideline Interpretation

  • You have access
    Interpretation of breast cancer screening guideline for Chinese women
    Yubei Huang, Zhongsheng Tong, Kexin Chen, Ying Wang, Peifang Liu, Lin Gu, Juntian Liu, Jinpu Yu, Fengju Song, Wenhua Zhao, Yehui Shi, Hui Li, Huaiyuan Xiao and Xishan Hao
    Cancer Biology & Medicine November 2019, 16 (4) 825-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0322

Erratum

  • You have access
    Erratum to Simultaneous inhibition of PI3Ka and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
    Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding and Linghua Meng
    Cancer Biology & Medicine November 2019, 16 (4) 836; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0401
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 16 (4)
Cancer Biology & Medicine
Vol. 16, Issue 4
1 Nov 2019
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article
  • Guideline
  • Guideline Interpretation
  • Erratum

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire